There are 2789 resources available
1107P - Durvalumab plus tremelimumab in patients with grade 3 neuroendocrine neoplasms of gastroenteropancreatic origin: Updated results from the multicenter phase II DUNE trial (GETNE 1601)
Presenter: Jaume Capdevila
Session: ePoster Display
1108P - Folfirinox in the treatment of advanced gastroenteropancreatic neuroendocrine carsinomas
Presenter: Baddar Pervaiz Butt
Session: ePoster Display
1109P - The psychological impact of COVID-19 pandemic on patients with NETs: Between resilience and vulnerability
Presenter: Eleonora Lauricella
Session: ePoster Display
1033TiP - A first-in-human phase I study of FS120, an OX40/CD137 tetravalent bispecific antibody, in patients with advanced malignancies
Presenter: Kyriakos Papadopoulos
Session: ePoster Display
1034TiP - ARTISTRY-6: Nemvaleukin alfa monotherapy in patients with advanced mucosal and cutaneous melanoma
Presenter: Richard Carvajal
Session: ePoster Display
1114P - Comparative study of combined large cell neuroendocrine carcinoma and combined small cell carcinoma in resected high-grade neuroendocrine tumors of the lung
Presenter: Yanan Wang
Session: ePoster Display
1115P - Beyond classic hereditary neuroendocrine tumors (NET) syndromes
Presenter: Carmen Castillo Manzano
Session: ePoster Display
1116P - Well-differentiated neuroendocrine tumors of the kidney: Clinical characterics and treatment outcomes of a very rare disease
Presenter: Leonidas Apostolidis
Session: ePoster Display
1117P - Mutational landscape of large cell neuroendocrine lung carcinoma: Molecular characterization using next generation sequencing
Presenter: Maria San Roman-Gil
Session: ePoster Display
1118P - Angioside: The role of angiogenesis in lung neuroendocrine tumors according to primary tumor location in left or right parenchyma
Presenter: Anna La Salvia
Session: ePoster Display